Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
M.D. Anderson Cancer Center
Kestrel Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
National Cancer Institute, Naples
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
Mayo Clinic
University of Wisconsin, Madison
University of Pittsburgh
The Netherlands Cancer Institute
University of California, San Diego
The Methodist Hospital Research Institute
Memorial Sloan Kettering Cancer Center
Centre Leon Berard
Spanish Breast Cancer Research Group
NRG Oncology
University of California, San Francisco
First Hospital of China Medical University
Assistance Publique - Hôpitaux de Paris
Memorial Sloan Kettering Cancer Center
UMC Utrecht
Northwestern University
Gustave Roussy, Cancer Campus, Grand Paris
European Institute of Oncology
University of Washington
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Institut Paoli-Calmettes
Case Comprehensive Cancer Center
Mayo Clinic
Insel Gruppe AG, University Hospital Bern
All India Institute of Medical Sciences, Bhubaneswar
Stanford University
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Dana-Farber Cancer Institute
Mayo Clinic
University of Wisconsin, Madison
Xijing Hospital
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
University of Southern California
University Hospital Heidelberg
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
Grupo Español Multidisciplinar de Melanoma